Rural Health
Resources by Topic: Illicit drug use
Factors Associated with Gaps in Naloxone Knowledge: Evidence from a 2022 Great Plains Survey
Examines naloxone knowledge in Nebraska, such as familiarity with, access to, and competency administering naloxone. Analyzes 2022 Nebraska Annual Social Indicators Survey data with breakdowns according to respondent substance use, social and demographic data, and metro versus nonmetro location. Discusses issues such as naloxone access, education, and stigma related to opioid-related overdose deaths.
Author(s): Spencer Cooper-Ohm, Patrick Habecker, Ryan Humeniuk, Rick A. Bevins
Citation: Harm Reduction Journal, 21, 37
Date: 02/2024
view details
Examines naloxone knowledge in Nebraska, such as familiarity with, access to, and competency administering naloxone. Analyzes 2022 Nebraska Annual Social Indicators Survey data with breakdowns according to respondent substance use, social and demographic data, and metro versus nonmetro location. Discusses issues such as naloxone access, education, and stigma related to opioid-related overdose deaths.
Author(s): Spencer Cooper-Ohm, Patrick Habecker, Ryan Humeniuk, Rick A. Bevins
Citation: Harm Reduction Journal, 21, 37
Date: 02/2024
view details
West Virginia Office of Drug Control Policy, 2024 Priorities and Implementation Plan
Outlines West Virginia's plan to prevent and treat substance use disorder throughout the state. Details goals for prevention, treatment, research, education, law enforcement, pregnant and parenting women, and the criminal justice system, pertaining to substance use disorder. Also discusses infectious diseases, such as hepatitis and HIV, resulting from substance abuse and misuse.
Date: 01/2024
Sponsoring organization: West Virginia Department of Health and Human Resources
view details
Outlines West Virginia's plan to prevent and treat substance use disorder throughout the state. Details goals for prevention, treatment, research, education, law enforcement, pregnant and parenting women, and the criminal justice system, pertaining to substance use disorder. Also discusses infectious diseases, such as hepatitis and HIV, resulting from substance abuse and misuse.
Date: 01/2024
Sponsoring organization: West Virginia Department of Health and Human Resources
view details
Stakeholder Perspectives on a Telemedicine Referral and Coordination Model To Expand Medication Treatment for Opioid Use Disorder in Rural Primary Care Clinics
Examines acceptability of utilizing an external telemedicine (TM) vendor to improve access to medications for opioid use disorder (MOUD) in rural areas. Analyzes interview data from 7 rural primary care clinics and a TM-MOUD vendor to explore themes such as logistical barriers, stigma, privacy, and access. Includes demographic data on survey respondents as well as acceptability ratings.
Author(s): Allison J. Ober, Alex R. Dopp, Sarah E. Clingan, et al.
Citation: Journal of Substance Use and Addiction Treatment, 156, 209194
Date: 01/2024
view details
Examines acceptability of utilizing an external telemedicine (TM) vendor to improve access to medications for opioid use disorder (MOUD) in rural areas. Analyzes interview data from 7 rural primary care clinics and a TM-MOUD vendor to explore themes such as logistical barriers, stigma, privacy, and access. Includes demographic data on survey respondents as well as acceptability ratings.
Author(s): Allison J. Ober, Alex R. Dopp, Sarah E. Clingan, et al.
Citation: Journal of Substance Use and Addiction Treatment, 156, 209194
Date: 01/2024
view details
Medicaid Coverage of Medications to Reverse Opioid Overdose and Treat Alcohol and Opioid Use Disorders
Report discusses access to medications for treating alcohol use disorder (AUD) and opioid use disorder (OUD) via Medicaid. Highlights policies and regulations that effect access and details Medicaid coverage in all 50 states, the District of Columbia, the U.S Virgin Islands, and Puerto Rico. Features a discussion about rural access.
Date: 01/2024
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Report discusses access to medications for treating alcohol use disorder (AUD) and opioid use disorder (OUD) via Medicaid. Highlights policies and regulations that effect access and details Medicaid coverage in all 50 states, the District of Columbia, the U.S Virgin Islands, and Puerto Rico. Features a discussion about rural access.
Date: 01/2024
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
A Federally Qualified Health Center and Certified Community Behavioral Health Clinic Partnership in Rural Missouri
Case study describing a medication for opioid use disorder (MOUD) program partnership between a Federally Qualified Health Center and a certified community behavioral health clinic in rural southwest Missouri. Covers the infrastructure of the MOUD program, staffing and services, financing, and more. Highlights challenges and successes, as well as recommendations for other health centers interested in a similar partnership.
Author(s): Ashley Jasko, Meryl Schulman
Date: 01/2024
Sponsoring organization: Center for Health Care Strategies
view details
Case study describing a medication for opioid use disorder (MOUD) program partnership between a Federally Qualified Health Center and a certified community behavioral health clinic in rural southwest Missouri. Covers the infrastructure of the MOUD program, staffing and services, financing, and more. Highlights challenges and successes, as well as recommendations for other health centers interested in a similar partnership.
Author(s): Ashley Jasko, Meryl Schulman
Date: 01/2024
Sponsoring organization: Center for Health Care Strategies
view details
El Dorado Community Health Centers: Addressing the Opioid Epidemic in Rural California through Community Partnerships
Case study describing how El Dorado Community Health Centers, a Federally Qualified Health Center (FQHC) in California, works with a community coalition to address the opioid epidemic and implement a medication for opioid use disorder (MOUD) program. Covers the infrastructure of the MOUD program, staffing and services, financing, and more. Highlights challenges and successes, as well as recommendations for other health centers.
Author(s): Ashley Jasko, Meryl Schulman
Date: 01/2024
Sponsoring organization: Center for Health Care Strategies
view details
Case study describing how El Dorado Community Health Centers, a Federally Qualified Health Center (FQHC) in California, works with a community coalition to address the opioid epidemic and implement a medication for opioid use disorder (MOUD) program. Covers the infrastructure of the MOUD program, staffing and services, financing, and more. Highlights challenges and successes, as well as recommendations for other health centers.
Author(s): Ashley Jasko, Meryl Schulman
Date: 01/2024
Sponsoring organization: Center for Health Care Strategies
view details
Association of Spatial Proximity to Fixed-Site Syringe Services Programs with HCV Serostatus and Injection Equipment Sharing Practices Among People Who Inject Drugs in Rural New England, United States
Examines the correlation of proximity to a syringe services program (SSP) and Hepatitis C virus (HCV) infection in rural areas of the northeastern United States. Utilizes 2018-2019 data to analyze people who inject drugs (PWID) and their demographic characteristics, drug usage, and distance to the nearest fixed-site SSP.
Author(s): Eric Romo, Thomas J. Stopka, Bill M. Jesdale, et al.
Citation: Harm Reduction Journal, 21, 23
Date: 01/2024
view details
Examines the correlation of proximity to a syringe services program (SSP) and Hepatitis C virus (HCV) infection in rural areas of the northeastern United States. Utilizes 2018-2019 data to analyze people who inject drugs (PWID) and their demographic characteristics, drug usage, and distance to the nearest fixed-site SSP.
Author(s): Eric Romo, Thomas J. Stopka, Bill M. Jesdale, et al.
Citation: Harm Reduction Journal, 21, 23
Date: 01/2024
view details
The Impact of Fentanyl on State- and County-Level Psychostimulant and Cocaine Overdose Death Rates by Race in Ohio from 2010 to 2020: A Time Series and Spatiotemporal Analysis
Analyzes the role of fentanyl in overdose deaths in Ohio. Examines 2010-2020 state- and county-level overdose mortality rates with data further broken down by drug type and race/ethnicity. Discusses related geographical factors such as rurality and Appalachian region.
Author(s): Angela T. Estadt, Brian N. White, JaNelle M. Ricks, et al.
Citation: Harm Reduction Journal, 21, 13
Date: 01/2024
view details
Analyzes the role of fentanyl in overdose deaths in Ohio. Examines 2010-2020 state- and county-level overdose mortality rates with data further broken down by drug type and race/ethnicity. Discusses related geographical factors such as rurality and Appalachian region.
Author(s): Angela T. Estadt, Brian N. White, JaNelle M. Ricks, et al.
Citation: Harm Reduction Journal, 21, 13
Date: 01/2024
view details
Opioid Overdose Surveillance Preliminary District Report: Georgia, 2022
Describes district-level fatal and nonfatal opioid-involved overdoses that occurred in Georgia 2020-2022. Covers prescription opioids and illicit opioids, including heroin, fentanyl, and fentanyl analogs. Features statistics on demographics, overdose deaths, and emergency department visits, with breakdowns by district, drug type, and year. The Preliminary County Report contains county-by-county data.
Additional links: County Report
Date: 01/2024
Sponsoring organization: Georgia Department of Public Health
view details
Describes district-level fatal and nonfatal opioid-involved overdoses that occurred in Georgia 2020-2022. Covers prescription opioids and illicit opioids, including heroin, fentanyl, and fentanyl analogs. Features statistics on demographics, overdose deaths, and emergency department visits, with breakdowns by district, drug type, and year. The Preliminary County Report contains county-by-county data.
Additional links: County Report
Date: 01/2024
Sponsoring organization: Georgia Department of Public Health
view details
Mississippi State Department of Health 2024 Annual Report
Offers overview of public health indicators for residents of the state of Mississippi including mortality, teen birth rates, various health conditions, and vaccination. Discusses regulation and legislative changes, pharmaceutical programs, lab services, public health outreach, rural health and primary care, Health Professional Shortage Areas, and administrative updates.
Date: 2024
Sponsoring organization: Mississippi State Department of Health
view details
Offers overview of public health indicators for residents of the state of Mississippi including mortality, teen birth rates, various health conditions, and vaccination. Discusses regulation and legislative changes, pharmaceutical programs, lab services, public health outreach, rural health and primary care, Health Professional Shortage Areas, and administrative updates.
Date: 2024
Sponsoring organization: Mississippi State Department of Health
view details